Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies

由 Zhu, Qing-Ge, Zhang, Shi-Ming, Ding, Xiao-Xiao, He, Bing, Zhang, Hu-Qin
發表在 Oncotarget (2017)

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

由 Zhang, Shi-Ming, Zhu, Qing-Ge, Ding, Xiao-Xiao, Lin, Song, Zhao, Jing, Guan, Lei, Li, Ting, He, Bing, Zhang, Hu-Qin
發表在 Cancer Manag Res (2018)

Identifying key regulating miRNAs in hepatocellular carcinomas by an omics’ method

由 He, Bing, Lu, Peng, Guan, Lei, Li, Ting, Zhang, Lei, Zhu, Qing-Ge, Ding, Xiao-Xiao, Zhang, Shi-Ming, Chen, Xue-Mei, Zhao, Jing, Lin, Song, Liu, Zhi-Zhen, Liu, Fang-E, Ma, Wang, Zhang, Hu-Qin
發表在 Oncotarget (2017)

Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy

由 Ding, Xiao-Xiao, Zhu, Qing-Ge, Zhang, Shi-Ming, Guan, Lei, Li, Ting, Zhang, Lei, Wang, Shi-Yang, Ren, Wan-Li, Chen, Xue-Mei, Zhao, Jing, Lin, Song, Liu, Zhi-Zhen, Bai, Yan-Xia, He, Bing, Zhang, Hu-Qin
發表在 Oncotarget (2017)

MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma

由 Guan, Lei, Li, Ting, Ai, Nanping, Wang, Wei, He, Bing, Bai, Yanxia, Yu, Zhaocai, Li, Mingyue, Dong, Shanshan, Zhu, Qingge, Ding, Xiao Xiao, Zhang, Shiming, li, Ming, Tang, Guangbo, Xia, Xiaochun, Zhao, Jing, lin, Song, yao, Shi, zhang, Lei, chen, Geng, Liu, Fang-E, Li, Xinyuan, Zhang, Huqin
發表在 J Exp Clin Cancer Res (2019)